CosLeaguer Global
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
CosLeaguer Global distributes medical-aesthetic injectables, such as botulinum toxin (a muscle-relaxing treatment used in cosmetic procedures) and dermal fillers, and also manufactures and distributes skincare and cosmetic products.
Its customers include clinics and consumers seeking medical-beauty and skincare solutions, and it connects Korean-beauty brands with domestic and international influencer-commerce channels. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across four segments: healthcare distribution, cosmetics manufacturing, eco-friendly appliances, and new-media marketing.
Summary is AI-generated and may contain errors · figures from DART filings
The company wholly owns a dermacosmetics ODM manufacturing subsidiary, Cosleager, and has acquired Moments Company, operator of the skincare brand 'B'plain', to integrate planning, manufacturing, and distribution in-house.
CosLeaguer Global in five facts
What does CosLeaguer Global do?
CosLeaguer Global distributes medical-aesthetic injectables, such as botulinum toxin (a muscle-relaxing treatment used in cosmetic procedures) and dermal fillers, and also manufactures and distributes skincare and cosmetic products.
Where is CosLeaguer Global listed and in which sector?
CosLeaguer Global (Korean name: 코스리거글로벌) trades under KRX code 043710 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Trading & Distribution.
How large is CosLeaguer Global?
Its market capitalisation was US$37.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were CosLeaguer Global's latest annual revenue and operating profit?
For fiscal year 2025, CosLeaguer Global reported revenue of US$26.9M, an operating loss of US$6.3M and a net loss of US$6.6M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 84.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Half-year report (2026.06)Oct 7
- Report on large shareholdings (5% rule) (standard)Sep 14
- Report on large shareholdings (5% rule) (standard)Sep 4
- Material event report (decision to redeem own convertible bonds early)
CosLeaguer Global's board decided on 2026-08-03 to redeem US$24.5M in face value of its Series 4 convertible bonds early from its ultimate controlling shareholder, FINTEK CO., LIMITED, for US$25.2M including principal and interest, with plans to retire the bonds in full.
Capital raise · Aug 4 - [Amended] Material event report (convertible bonds)
CosLeaguer Global updated the terms of convertible bonds to raise US$35.2M, about 93.8% of its market value.
Capital raise · Jul 31 - Operating results (consolidated) (preliminary) (fair disclosure)
CosLeaguer Global filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$26.8M (+816.2% year on year), operating profit of US$1.04M (from a loss a year earlier) and a net loss of US$1.95M.
Earnings · May 4 - Trading suspension (share consolidation/split registration)M&A · Apr 9
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
CosLeaguer Global reported consolidated results for FY2025: revenue of US$24.4M (+84.4% year on year), an operating loss of US$5.69M and a net loss of US$7.35M (from a profit a year earlier).
Earnings · Mar 10